商务合作
动脉网APP
可切换为仅中文
Renens-based Autonomyo, which specializes in medical technology and was founded at EPFL, has raised €1.4 million from private and public investors and is now launching a crowdfunding campaign on Capital Cell to develop its home rehabilitation technology internationally.
总部位于勒内恩的Autonomyo公司专注于医疗技术,成立于洛桑联邦理工学院(EPFL),已从私人和公共投资者处筹集了140万欧元,目前正通过Capital Cell平台发起众筹活动,以推动其家庭康复技术的国际发展。
With its Skywalk product, a safety system combined with a smart exoskeleton and a digital therapy platform, Autonomyo is bringing robot-assisted rehabilitation from the clinic directly to patients' homes.
通过其Skywalk产品(一种结合智能外骨骼和数字治疗平台的安全系统),Autonomyo正在将机器人辅助康复从诊所直接带到患者的家中。
Every year, over 15 million people suffer a stroke. Half of them leave rehabilitation still unable to walk independently — not because recovery isn’t possible, but because intensive therapy is too costly and inaccessible.
每年,有一千五百多万人中风。 其中一半人在康复训练后 仍然无法独立行走—— 并不是因为他们无法恢复, 而是因为高强度的治疗 太过昂贵,而且不容易接受到治疗。
Autonomyo
自主性
, a Swiss MedTech spin-off from EPFL, is changing this reality with
,一家从EPFL分拆出来的瑞士医疗科技公司,正在通过
Skywalk
空中走廊
, the world’s first intelligent safety frame that enables
,世界上第一个实现智能的安全框架
safe, assisted
安全的,辅助的
gait training at home
在家步态训练
. Combined with Autonomyo’s wearable exoskeleton and digital rehabilitation platform, it empowers patients to train daily, safely, and affordably — wherever they are.
结合Autonomyo的可穿戴外骨骼和数字康复平台,它使患者能够随时随地进行日常、安全且负担得起的训练。
After raising
提升后
€1.4 million
140万欧元
from public and private investors, Autonomyo is now opening its
来自公私投资者的Autonomyo现在正在开放其
Capital Cell crowdfunding campaign
资本细胞众筹活动
to engage the community in its mission to give millions their independence back. “We’re building a future where effective rehabilitation is no longer limited to the hospital,” says
让社区参与到其使命中,为数百万人重新获得独立性。“我们正在建设一个未来,有效的康复不再局限于医院,”他说。
Fabian Bischof
费边·比朔夫
, CEO and co-founder. “Skywalk lets patients train safely at home — it’s affordable, empowering, and life-changing.”
,首席执行官兼联合创始人。“Skywalk让患者能够安全地在家训练——它价格实惠、赋予力量,并且改变生活。”
The company has already completed
公司已经完成
successful clinical trials
成功的临床试验
at CHUV (University Hospital of Lausanne) and is preparing
在洛桑大学医院 (CHUV) 并正在准备
CE certification and FDA
CE认证和FDA
readiness
就绪状态
for 2025. Now, through crowdfunding, Autonomyo aims to accelerate the
面向2025年。现在,通过众筹,Autonomyo希望加速这一进程。
industrialization of its
工业化
Skywalk and Exoskeleton V3
天桥和外骨骼 V3
, expand its
,扩展其
digital training
数字培训
content
内容
, and bring the solution to thousands of homes worldwide.
,并将解决方案带到全球成千上万的家庭。
To take part in the movement in order to help millions walk again, you can join
为了参与这项运动,帮助数百万人再次行走,您可以加入我们。
the campaign here:
这里的活动:
https://capitalcell.com/en/campaign/autonomyo/
https://capitalcell.com/en/campaign/autonomyo/
(PR)
公共关系
0
0
Comments
评论
Back to all news
返回所有新闻
Please
请
login
登录
or
或
sign up
注册
to comment.
评论。
Commenting guidelines
评论指南
Send
发送